Bystanders or not? Microglia and lymphocytes in aging and strokeJustin N.Nguyen，Anjali Chauhan1397-1403
Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegenerationEugenia Olivera，Albany Sáez，Lila Carniglia，Carla Caruso，Mercedes Lasaga，Daniela Durand1404-1410
Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseasesAna M.Sandoval-Castellanos，Anushka Bhargava，Min Zhao，Jun Xu，Ke Ning1411-1416
Can glial cells save neurons in epilepsy?Weida Shen，Jelena Bogdanovi? Pristov，Paola Nobili，Ljiljana Nikoli?1417-1422
Lights for epilepsy: can photobiomodulation reduce seizures and offer neuroprotection?Napoleon Torres-Martinez，Stephan Chabardes，John Mitrofanis1423-1426
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosisIlaria Martinelli，Elisabetta Zucchi，Cecilia Simonini，Giulia Gianferrari，Giovanna Zamboni，Marcello Pinti，Jessica Mandrioli1427-1433
CMT1A current gene therapy approaches and promising biomarkersMarina Stavrou，Kleopas A.Kleopa1434-1440
Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surfaceDan-Dan Liu，Chao-Yang Zhang，Jing-Ting Zhang，Li-Min Gu，Guo-Tong Xu，Jing-Fa Zhang1441-1449
Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's diseaseTamara Andrea Alarcón，Sarah Martins Presti-Silva，Ana Paula Toniato Sim?es，Fabiola Mara Ribeiro，Rita Gomes Wanderley Pires1450-1456
Regulation of enolase activation to promote neural protection and regeneration in spinal cord injuryHannah M.McCoy，Rachel Polcyn，Naren L.Banik，Azizul Haque1457-1462
